<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zdor</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы здоровья и экологии</journal-title><trans-title-group xml:lang="en"><trans-title>Health and Ecology Issues</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2220-0967</issn><issn pub-type="epub">2708-6011</issn><publisher><publisher-name>Gomel State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51523/2708-6011.2016-13-2-11</article-id><article-id custom-type="elpub" pub-id-type="custom">zdor-1691</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL MEDICINE</subject></subj-group></article-categories><title-group><article-title>КЛИНИКО-МОРФОЛОГИЧЕСКИЙ АНАЛИЗ ТРОЙНОГО НЕГАТИВНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ ВЫЯВЛЕННОГО В ГОМЕЛЬСКОЙ ОБЛАСТИ В 2014 ГОДУ</article-title><trans-title-group xml:lang="en"><trans-title>THE CLINICAL AND MORPHOLOGICAL ANALYSIS OF TRIPLE NEGATIVE BREAST CANCER REVEALED IN GOMEL REGION IN 2014</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крылов</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Krylov</surname><given-names>A. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крылов</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Krylov</surname><given-names>Yu. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ачинович</surname><given-names>С. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Achinovich</surname><given-names>S. L.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мартемьянова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Martemyanova</surname><given-names>L. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Турченко</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Turchenko</surname><given-names>S. Y.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт повышения квалификации и переподготовки кадров Государственного комитета судебных экспертиз Республики Беларусь</institution></aff><aff xml:lang="en"><institution>Institute of Improvement of Professional Skill and Retraining of Personnel of the State Committee of Judicial Examinations of Belarus</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Витебское областное клиническое патологоанатомическое бюро</institution></aff><aff xml:lang="en"><institution>Vitebsk Regional Clinical Pathoanatomical Bureau</institution></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Гомельский областной клинический онкологический диспансер</institution></aff><aff xml:lang="en"><institution>Gomel Regional Clinical Oncological Clinic</institution></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Гомельский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Gomel State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>28</day><month>06</month><year>2016</year></pub-date><volume>0</volume><issue>2</issue><fpage>53</fpage><lpage>57</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Крылов А.Ю., Крылов Ю.В., Ачинович С.Л., Мартемьянова Л.А., Турченко С.Ю., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Крылов А.Ю., Крылов Ю.В., Ачинович С.Л., Мартемьянова Л.А., Турченко С.Ю.</copyright-holder><copyright-holder xml:lang="en">Krylov A.Y., Krylov Y.V., Achinovich S.L., Martemyanova L.A., Turchenko S.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.gsmu.by/jour/article/view/1691">https://journal.gsmu.by/jour/article/view/1691</self-uri><abstract><p>Цель: изучить клинико-морфологические характеристики тройного негативного рака молочной железы (ТНРМЖ), выявленного в Гомельской области в 2014 г. Материалы и методы . Материалом исследования стали 85 случаев ТНРМЖ, выявленного в Гомельской области в 2014 г. Клинико-морфологический анализ проводился по базе данных патологоанатомического отделения У «Гомельский областной клинический онкологический диспансер». Результаты. ТНРМЖ в 2014 году был установлен в 85 наблюдениях из 412 случаев РМЖ, что составило 20,6 %. Сходные результаты в этом же году получены в Витебской области - 82 наблюдения из 425 (19,3 %) и Гродненской области - 77 наблюдений из 380 (20 %). Средний возраст пациенток с ТНРМЖ составил 56,0 года, что соответствует литературным данным и практически не отличается от данных, полученных в Витебской - 55,8 года и Гродненской области - 56,5 года. Вывод. Результаты изучения гистологической степени злокачественности, показателей прогноза (TNM) и соотношения клинических стадий подтвердили данные литературных источников о более неблагоприятной прогностической значимости выявления ТНРМЖ. Клинико-морфологические характеристики ТНРМЖ, выявленного в Гомельской области в 2014 г., соответствуют данным научных публикаций и результатам, полученным при их изучении в других регионах Республики Беларусь.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to study the clinical and morphological characteristics of triple negative breast cancer (TNBC) revealed in Gomel region in 2014. Material and methods . The material of the study became 85 cases of TNBC revealed in Gomel region in 2014. The clinical and morphological analysis was made on the database of the Pathoanatomical Branch of the Gomel Regional Clinical Oncological Clinic. Results . In the year of 2014 TNBC was detected in 85 out of 412 cases of BC, which made up 20.6 %. The similar results in the same year were received in Vitebsk region - 82 out of 425 (19.3 %) and Grodno region - 77 out of 380 (20 %). The average age of the patients with TNBC was 56.0 years, which corresponded to literary data and practically did not differ from the data received in Vitebsk region - 55.8 years and Grodno region - 56.5 years. Conclusion. The results of the study of the histological degree of malignancy, prediction indicators (TNM) and parities of clinical stages have confirmed the data of the given literary sources on more adverse prognostic value of TNBC detection. The clinical and morphological characteristics of TNBC revealed in Gomel region in the year of 2014 correspond to the data of literary sources and the results received during the study in other regions of Belarus.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>иммуногистохимия</kwd><kwd>тройной негативный рак молочной железы</kwd><kwd>клинико-морфологический анализ</kwd><kwd>Гомельская область</kwd><kwd>immunohistochemistry</kwd><kwd>triple negative breast cancer</kwd><kwd>clinical and morphological analysis</kwd><kwd>Gomel region</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации. Онкология / В. И. Чиссов [и др.]. ; под ред. В. И. Чиссова. - 2-е изд., испр. и доп. - М.: ГЭОТАР-Медиа, 2009. - 928 с.</mixed-citation><mixed-citation xml:lang="en">Клинические рекомендации. Онкология / В. И. Чиссов [и др.]. ; под ред. В. И. Чиссова. - 2-е изд., испр. и доп. - М.: ГЭОТАР-Медиа, 2009. - 928 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Состояние онкологической помощи населению России в 2011 году / В. И. Чиссов [и др.]; под ред. В. И. Чиссова. - М.: ФГБУ «МНИОИ им. П. А. Герцена Минздравсоцразвития РФ», 2012. - 240 с.</mixed-citation><mixed-citation xml:lang="en">Состояние онкологической помощи населению России в 2011 году / В. И. Чиссов [и др.]; под ред. В. И. Чиссова. - М.: ФГБУ «МНИОИ им. П. А. Герцена Минздравсоцразвития РФ», 2012. - 240 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pattern of metastatic spread in triple-negative breast cancer / R. Dent [et al.] // Breast Cancer Res. Treat. - 2008. - Vol. 115, № 2. - P. 423-428.</mixed-citation><mixed-citation xml:lang="en">Pattern of metastatic spread in triple-negative breast cancer / R. Dent [et al.] // Breast Cancer Res. Treat. - 2008. - Vol. 115, № 2. - P. 423-428.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nishimura, R. Is triple negative a prognostic factor in breast cancer? / R. Nishimura, N. Arima // Breast Cancer. - 2008. - Vol. 15, № 4. - P. 303-308.</mixed-citation><mixed-citation xml:lang="en">Nishimura, R. Is triple negative a prognostic factor in breast cancer? / R. Nishimura, N. Arima // Breast Cancer. - 2008. - Vol. 15, № 4. - P. 303-308.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype / M. C. Cheang [et al.] // Clin. Canceres. - 2008. - Vol. 14, № 5. - P. 1368-1376.</mixed-citation><mixed-citation xml:lang="en">Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype / M. C. Cheang [et al.] // Clin. Canceres. - 2008. - Vol. 14, № 5. - P. 1368-1376.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical outcomes after a diagnosis of brain metastases in patients with estrogen and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer / S. L. Hines [et al.] // Ann. Oncol. - 2008. - Vol. 19, № 9. - P. 1561-1565.</mixed-citation><mixed-citation xml:lang="en">Clinical outcomes after a diagnosis of brain metastases in patients with estrogen and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer / S. L. Hines [et al.] // Ann. Oncol. - 2008. - Vol. 19, № 9. - P. 1561-1565.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Single centre clinical of a Greek patient population with triple-negative breast cancer / D. Panousis [et al.] // Hellenic Journal of Surgery. - 2014. - Vol. 86, № 5. - P. 280-286.</mixed-citation><mixed-citation xml:lang="en">Single centre clinical of a Greek patient population with triple-negative breast cancer / D. Panousis [et al.] // Hellenic Journal of Surgery. - 2014. - Vol. 86, № 5. - P. 280-286.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and results database / G. J. Morris [et al.] // Cancer. - 2007. - Vol. 110, № 4. - P. 876-884.</mixed-citation><mixed-citation xml:lang="en">Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and results database / G. J. Morris [et al.] // Cancer. - 2007. - Vol. 110, № 4. - P. 876-884.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">High prevalence of triple-negative tumors in an urban cancer center / M. J. Butler [et al.] // Cancer. - 2008. - Vol. 113, № 3. - P. 608-615.</mixed-citation><mixed-citation xml:lang="en">High prevalence of triple-negative tumors in an urban cancer center / M. J. Butler [et al.] // Cancer. - 2008. - Vol. 113, № 3. - P. 608-615.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Риск развития рака молочной железы после воздействия ионизирующего излучения вследствие Чернобыльской катастрофы / Е. Я. Сосновская [и др.] // Журнал «Медицинские новости». - 2006. - № 3. - С. 31-36.</mixed-citation><mixed-citation xml:lang="en">Риск развития рака молочной железы после воздействия ионизирующего излучения вследствие Чернобыльской катастрофы / Е. Я. Сосновская [и др.] // Журнал «Медицинские новости». - 2006. - № 3. - С. 31-36.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basallike breast carcinomas) / E. Lerma [et al.] // Mod. Pathol. - 2007. - Vol. 20, № 11. - P. 1200-1207.</mixed-citation><mixed-citation xml:lang="en">Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basallike breast carcinomas) / E. Lerma [et al.] // Mod. Pathol. - 2007. - Vol. 20, № 11. - P. 1200-1207.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Identificaation of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression / Gilda Schmidt [et al.] // Arch. Gynecol Obster. - 2014. - Vol. 209. - P. 1221-1229.</mixed-citation><mixed-citation xml:lang="en">Identificaation of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression / Gilda Schmidt [et al.] // Arch. Gynecol Obster. - 2014. - Vol. 209. - P. 1221-1229.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive / Van Calster B. [et al.] // Breast Cancer Res. Treat. - 2009. - Vol. 113, № 1. - P. 181-187.</mixed-citation><mixed-citation xml:lang="en">Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive / Van Calster B. [et al.] // Breast Cancer Res. Treat. - 2009. - Vol. 113, № 1. - P. 181-187.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases / Z. Y. Yuan [et al.] // Ai Zheng. - 2008. - Vol. 27, № 6. - P. 561-565.</mixed-citation><mixed-citation xml:lang="en">Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases / Z. Y. Yuan [et al.] // Ai Zheng. - 2008. - Vol. 27, № 6. - P. 561-565.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer / B. G. Haffty [et al.] // J. Clin. Oncol. - 2006. - Vol. 24. - P. 5652-5657.</mixed-citation><mixed-citation xml:lang="en">Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer / B. G. Haffty [et al.] // J. Clin. Oncol. - 2006. - Vol. 24. - P. 5652-5657.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients / W. J. Yin [et al.] // Breast Cancer Res. Treat. - 2009. - Vol. 115, № 2. - Р. 325-333.</mixed-citation><mixed-citation xml:lang="en">Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients / W. J. Yin [et al.] // Breast Cancer Res. Treat. - 2009. - Vol. 115, № 2. - Р. 325-333.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
